Overview
Portfolio
More
Cannagecap
Invests in interdisciplinary early‑stage companies focusing on AI/Data, Cybersecurity and digital health.
Portfolio
10+
Employees
<3
Founded
2024
AUM
≈ $0.0
Investment focus
Stages
No stages listed
Industries
No industries listedSources
Cannagecap
Invests in interdisciplinary early‑stage companies focusing on AI/Data, Cybersecurity and digital health.
Portfolio
10+
Employees
<3
Founded
2024
AUM
≈ $0.0
Showing 10 of 10 matched portfolio companies
Covariant develops the Covariant Brain, an AI robotics platform designed to automate warehouse operations. This platform utilizes a multimodal robotics dataset to enable robots to pick diverse SKUs with high autonomy from day one. The system leverages fleet learning to adapt to changing business needs and scale fulfillment capabilities.
Funding: $75.0M
Rough estimate of the amount of funding raised
Funding: $75.0M
Rough estimate of the amount of funding raised
Super Cruise is an integrated hands‑free driver assistance system for GM vehicles that combines camera, radar and HD‑map data to automate acceleration, braking, steering and lane changes on a mapped highway network. The platform includes driver‑attention monitoring, OTA updates and OnStar connectivity, and is offered through a subscription model to individual owners and commercial fleets.
Deep Genomics utilizes a proprietary AI platform to analyze complex RNA biology data, identifying novel therapeutic targets for genetic conditions. By streamlining the drug discovery process, the company aims to develop RNA therapies that can precisely target genetic causes, significantly reducing the time and cost associated with traditional methods.
Funding: $180.0M
Rough estimate of the amount of funding raised
Funding: $180.0M
Rough estimate of the amount of funding raised
Forter provides a real-time identity intelligence platform that automates fraud prevention for online merchants by eliminating fake accounts and reducing chargebacks. This technology enhances transaction approval rates and optimizes payment processes, allowing businesses to focus on customer lifetime value while minimizing risk.
Ginkgo Bioworks provides autonomous laboratory platforms that replace manual bench work with robotic execution of experiments. Scientists can order experiments in natural language via a cloud interface, while the system handles liquid handling, incubation, and data capture, and offers on‑demand biological datasets and AI/ML models through its Datapoints service. The solution enables biotech, pharma, and agriculture companies to run high‑throughput, repeatable bioengineering workflows at scale.
Hinge Health provides a digital clinic for joint and muscle care, utilizing a mobile app that connects users with expert clinical care and personalized exercise programs. The platform effectively reduces pain by 68% and prevents 42% of new opioid prescriptions, making it accessible at no cost through over 2,000 employers and health plans.
Funding: $400.0M
Rough estimate of the amount of funding raised
Funding: $400.0M
Rough estimate of the amount of funding raised
HUMAN Security offers a real‑time fraud and bot mitigation platform that evaluates over 2,500 signals per interaction using a suite of 400+ adaptive machine‑learning models. The solution provides API‑driven decisioning, page‑level traffic intelligence, and AI‑agent visibility for ad tech, e‑commerce, and regulated enterprises, supporting compliance and transaction safety. Integrated dashboards deliver alerts and forensic reporting across advertising, application, and payment workflows.
JupiterOne provides a cyber asset analysis platform that consolidates asset, vulnerability, and compliance data through over 200 integrations, enabling security teams to gain complete visibility into their attack surface. The platform's graph-based architecture allows organizations to identify and prioritize risks associated with their cyber assets, facilitating proactive threat management and continuous compliance.
Funding: $119.0M
Rough estimate of the amount of funding raised
Funding: $119.0M
Rough estimate of the amount of funding raised
Noetik develops frontier AI models trained on extensive multimodal tumor data to predict individual patient responses to cancer treatments. This platform enhances clinical trial enrichment by accurately identifying likely responders for specific therapies. The technology aims to improve drug positioning and accelerate the discovery of novel, human-relevant oncology targets.
Funding: $54.0M
Rough estimate of the amount of funding raised
Funding: $54.0M
Rough estimate of the amount of funding raised
Sardine utilizes proprietary device intelligence and behavior biometrics to detect and prevent financial crimes such as identity fraud, payment fraud, and money laundering in real-time. The platform enables over 250 companies to automate risk decisioning and enhance compliance through tools for identity verification, AML monitoring, and case management.
Funding: $75.5M
Rough estimate of the amount of funding raised
Funding: $75.5M
Rough estimate of the amount of funding raised